. Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease. J Mol Neurosci. 2004;23(3):151-5. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments